| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| gsk1070916 | aurora kinase b | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Neoplasms[MeSHID:D009369] |
1.77 | phase 1 | unknown |
| gsk1070916 | aurora kinase b | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Neoplasms[MeSHID:D009369] |
1.77 | phase 1 | inhibitor |
| gsk1070916 | aurora kinase c | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Neoplasms[MeSHID:D009369] |
9.64 | phase 1 | inhibitor |
| gsk1070916 | aurora kinase c | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Neoplasms[MeSHID:D009369] |
9.64 | phase 1 | unknown |
| click here to return to the previous page | ||||||||